...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary
Reply New Message
Prev Message Back To Forum Threaded View Next Message

fouremm, I wasn't aware that "Judging by his comments during and after the meeting it would seem that taking the newco public is a high priority for him."

I was not aware of that. Thanks you. This makes me feel a bit more positive than when I posted yesterday. If Don achieves that soon I will be pleased and willing then to sit back and watch things unfold through 2022.

Regards

Toinv

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply